Skip to main content
logo
Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
26.40
-0.87 (-3.19%)
Jan 28, 2026, 4:00 PM EST - Market closed

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $84.07M in the quarter ending September 30, 2025, with 17.18% growth. This brings the company's revenue in the last twelve months to $315.55M, up 13.60% year-over-year. In the year 2024, Fulgent Genetics had annual revenue of $283.47M, down -1.99%.

Revenue (ttm)
$315.55M
Revenue Growth
+13.60%
P/S Ratio
2.57
Revenue / Employee
$240,327
Employees
1,313
Market Cap
816.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
Myriad Genetics825.30M
NeoGenomics709.16M
OPKO Health642.07M
GeneDx Holdings402.19M
Twist Bioscience376.57M
CareDx358.00M
Castle Biosciences343.53M
Revenue Rankings

FLGT News

More News